Skip to main content
. 2023 Feb 24;15(3):623. doi: 10.3390/v15030623

Table 1.

Animal IDs, SIV inoculum, infection duration, Δ9-THC administration, and ART treatment.

Animal ID Pre-Infection Sample Used SIV Inoculum Group 1
VEH/SIV
Group 2
THC/SIV
Group 3
VEH/SIV/cART
Group 4
THC/SIV
/cART
Group 5
THC/no SIV
Post-Infection Sample Collection
JD66 NA SIVmac251 Yes 1 & 5 MPI
IN24 NA SIVmac251 Yes 1 & 5 MPI
JH47 NA SIVmac251 Yes 1 & 5 MPI
JI45 NA SIVmac251 Yes 1 & 5 MPI
JC85 NA SIVmac251 Yes 1 & 5 MPI
JT80 NA SIVmac251 Yes 1 & 5 MPI
LM56 NA SIVmac251 Yes 1 & 5 MPI
LA88 NA SIVmac251 Yes 1 & 5 MPI
LN60 NA SIVmac251 Yes 1 & 5 MPI
LA55 NA SIVmac251 Yes 1 & 5 MPI
KV50 NA SIVmac251 Yes 1 & 5 MPI
LM85 NA SIVmac251 Yes 1 & 5 MPI
HI78 NA SIVmac251 No 1 & 5 MPT
HN79 NA SIVmac251 No 1 & 5 MPT
HN39 NA SIVmac251 No 1 & 5 MPT

NA—Not applicable. MPI—Months post infection. MPT—Months post treatment. Macaques in groups 3 and 4 received two injections of (50 mg/kg of anti-alpha4beta7) (LN60 and LM85) or control IgG (LM56) beginning 4 MPI at three-week intervals before the plasma sample at 5 MPI was collected. Macaques LN60, LM56, and LM85 received ART until 6 MPI. Macaques LA88, LA55, and KV50 received ART until 8 MPI (Table 2). However, samples used for this study were collected at 1 and 5 MPI.